Lodaat Pharma a company based in Chicago recently released from potatoes a prebiotic-resistant starch with an emphasis on sports nutrition and weight management. The ingredient produced is used specifically to increase butyrate production in the large intestine. With its Potato-Daat product, which contains 78 per cent resistant starch by weight, the company is targeting food and beverage brands. The ingredient can be formulated conveniently in a variety of applications like RTD beverages, milk, pills, and tablets. Butyrate is the most important short-chain fatty acid (SCFA) and has been associated with satiety promotion, protection against endothelial dysfunction and is useful for managing blood sugar.The company is working with colleagues at the University of Michigan on experiments directly using the ingredient.
The European Union has endorsed a health claim for resistant starch to mitigate postprandial glycemia, while in 2016 the FDA approved a certified health claim for highly amylose-resistant starch to "reduce the risk of type 2 diabetes" Moreover, a 2019 paper in mBio by Dr. Thomas Schmidt and his University of Michigan group revealed that "not all fermentable fibers are equally capable of stimulating SCFA production," and that resistant potato starch performed much better than resistant corn starch (RMS) in boosting butyrate levels.